Instituto Biomédico QUAES | IBQUAES
  • Instituto Biomédico QUAES | IBQUAES
  • Home
  • Cursos
  • Blog
  • Filosofía
  • Instalaciones
  • Profesorado
  • Escuela de verano
  • Contactar
  • Campus

Blood-based detection of pTau181 could identify pathological Alzheimer’s disease

9 marzo, 2020

Compartir en: Facebook Twitter LinkedIn

A recent advancement in the development of a blood test to detect pathological Alzheimer’s disease in people showing signs of dementia has been reported by researchers at the University of California San Francisco (UCSF; CA, USA). Their test focuses on the abnormal accumulation of pTau181.

Within the study, which has recently been published in Nature Medicine, researchers used this new test to measure the concentration of pTau181 in plasma samples of more than 400 participants (aged from 58 to 70). Their analysis demonstrated that pTau181 in plasma could differentiate healthy participants from those with Alzheimer’s pathology, as well as differentiate those with Alzheimer’s pathology from frontotemporal lobar degeneration.

Last updated: 5 March, 2020
AUTHORS: SHARON SALT, SENIOR EDITOR
https://www.neuro-central.com/

MÁS NOTICIAS DE ACTUALIDAD

¿Qué es una ecografía?
25 enero, 2023
Nuevos radiofármacos: la Medicina Nuclear como aliada para el diagnóstico y el abordaje terapéutico
2 enero, 2023
Instituto Biomédico QUAES | IBQUAES

© 2022 Ibquaes -Todos los derechos reservados  Aviso legal, Política de Privacidad, Cookies, Política de calidad.

Call Now ButtonPulsa para llamar